Mr. Alexander practices out of the New York office, where he focuses on securities fraud, corporate governance and shareholder rights litigation. Mr. Alexander was a principal member of the trial team that prosecuted In re Schering-Plough Corp./ENHANCE Securities Litigation and In re Merck & Co., Inc. Vytorin/Zetia Securities Litigation, which settled on the eve of trial for a combined $688 million. This $688 million settlement represents the largest securities class action recovery against a pharmaceutical company in history and is among the largest securities class action settlements of any kind. As lead associate on the firm’s trial team, Mr. Alexander helped achieve a $150 million settlement of investors’ claims against JPMorgan Chase arising from alleged misrepresentations concerning the trading activities of the so-called “London Whale.” He is currently prosecuting securities claims against Merck and others arising from alleged misrepresentations concerning the safety profile of Merck's pain-killer, VIOXX.
Prior to joining the firm, Mr. Alexander represented institutional clients in a number of high-profile securities, corporate governance, and antitrust matters.
Mr. Alexander was an award-winning member of his law school's national moot court team. Following law school, Mr. Alexander served as a judicial clerk to Chief Justice Michael L. Bender of the Colorado Supreme Court.
Super Lawyers selected Mr. Alexander as a New York “Rising Star” in recognition of his accomplishments.